Diabetes

Study highlights third-line treatment options for T2DM

(HealthDay)—Treatment escalation options have different efficacy following failure of exenatide or glimepiride added to metformin in patients with type 2 diabetes mellitus, according to a study published online April 1 ...

Diabetes

Fasting plasma glucose beats HbA1c for diabetes screening

(HealthDay)—For patients without diabetes undergoing coronary angiography (CAG), fasting plasma glucose (FPG) performs better in diabetes screening than glycated hemoglobin (HbA1c), according to a study published online ...

Diabetes

Bias may play a role in underdiagnoses of prediabetes

The accurate diagnosis of prediabetes in the primary care setting might depend on a patient's age, BMI, gender, race and certain comorbidities, according to research being presented at ENDO 2022, the Endocrine Society's annual ...

Diabetes

Poor glycemic control may up risk for stroke, death in T2DM

(HealthDay)—Poor glycemic control is associated with increased risks for stroke and death among patients with type 2 diabetes, according to a study published online Oct. 1 in Diabetes, Obesity and Metabolism.

page 6 from 12